Idexx Laboratories vs Stryker Corporation
Idexx Laboratories (IDXX) and Stryker Corporation (SYK) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $55B
- Last close
- $698.47
- 12 months
- +4.2%
- Market value
- $121B
- Last close
- $318.15
- 12 months
- −11.5%
At a glance
- By market value, Stryker Corporation ($121.1B) is about 2.2 times Idexx Laboratories ($55.0B).
- Over the last 12 months Idexx Laboratories's share price moved +4.2% and Stryker Corporation's −11.5%; against the S&P 500 that is −6.4 points and −22.1 points.
- In their last fiscal years Idexx Laboratories kept 24.6% of revenue as net income and Stryker Corporation 12.9%.
- In the last 90 days insiders reported 0 open-market purchases at Idexx Laboratories and 1 at Stryker Corporation; members of Congress disclosed 0 trades in Idexx Laboratories and 2 in Stryker Corporation.
- Next results: Idexx Laboratories Feb 1, 2027, Stryker Corporation Jan 27, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Idexx Laboratories IDXXNASDAQ · Health Care Equipment | Stryker Corporation SYKNYSE · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $55B | $121B |
| Revenue, last fiscal year | $4.3B | $25.1B |
| Net income, last fiscal year | $1.06B | $3.25B |
| Net marginNet income as a share of revenue | 24.6% | 12.9% |
| Free cash flow | $1.06B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Idexx Laboratories against
Common questions
How is Idexx Laboratories different from Stryker Corporation?
Idexx Laboratories (IDXX) is in Health Care Equipment on NASDAQ, with $4.3B of revenue in its last fiscal year and a net margin of 24.6%. Stryker Corporation (SYK) is in Health Care Equipment on NYSE, with $25.1B of revenue in its last fiscal year and a net margin of 12.9%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Idexx Laboratories and Stryker Corporation compare in size?
Stryker Corporation has the larger market value: Idexx Laboratories $55B and Stryker Corporation $121B, at the last close.
Whose share price rose more over the last 12 months, IDXX or SYK?
Over the last 12 months Idexx Laboratories moved +4.2% and Stryker Corporation −11.5%. Past price moves say nothing about the future.
Which has had more insider buying, Idexx Laboratories or Stryker Corporation?
Since 2006, Stryker Corporation insiders reported 40 open-market purchases against 24 for Idexx Laboratories. These are counts of what was filed, not a view on either stock.
Do members of Congress trade IDXX or SYK?
In the last 12 months, members of Congress disclosed 2 trades in Idexx Laboratories (IDXX) and 11 in Stryker Corporation (SYK).
When did insiders last buy IDXX and SYK?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Idexx Laboratories pageStryker Corporation pageRare insider trades this weekAll comparisons
https://oqro.io/compare/idxx-vs-syk







